- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01721889
Radiostereometric Analysis of Spine Arthrodesis
June 10, 2013 updated by: OAD Orthopaedics
The primary objective of this pilot study is to determine the precision of post-operative radiostereometric measurements for the assessment of lumbar spinal fusion.
This study will also determine the potential for RSA as a more precise and accurate means for assessment of lumbar spinal fusion and diagnosis of pseudarthrosis.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: John Andreshak, MD
- Phone Number: 630-225-2663
- Email: john.andreshak@oadortho.com
Study Locations
-
-
Illinois
-
Warrenville, Illinois, United States, 60555
- Recruiting
- OAD Orthopaedics
-
Principal Investigator:
- John Andreshak, MD
-
Sub-Investigator:
- Stephen Heim, MD
-
Sub-Investigator:
- Jerome Kolavo, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients between the ages of 18 and 75 that are diagnosed with lumbar DDD (L1-L5, and also L5-S1) and scheduled for one or multi level spinal fusion surgery will be recruited for the study.
Description
Inclusion Criteria:
- Symptomatic degenerative disc disease of the lumbar spine indication surgical intervention
- Scheduled to undergo lumbar fusion surgery
- Patients between the ages of 18 and 75
- Ability to give informed consent
Exclusion Criteria:
- Pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Radiostereometric analysis - Intact fusion
Clinically fused per classical radiographic assessment (≤ 2 degrees angular motion and evidence of bone bridging)
|
The radiostereometric (RSA) patient exam (flexion and extension RSA images) presents additional radiation exposure to the patient above standard of care (additional radiographs).
Assuming 120kV, using three protocols (two loaded and one unloaded) per RSA exam results in a typical effective dose of approximately 2.04mSv per exam(single lumbar spine RSA at 120kV yields 0.68mSv,).
HBI recommends using 140kV for lumbar spine RSA and has conducted simulations to estimate the effective dose using higher kV settings.
140kV reduces the effective dose from 0.68mSv per spine RSA to 0.2mSV, resulting in a total effective dose per RSA exam of 0.6mSv.
In comparison, the estimated effective dose for a single standard lumbar spine x-ray is 1.2mSv.
This additional radiation exposure is considered to be minimal risk in consideration of the number of planar x-rays the patient will undergo as part of standard care, as well as average background radiation received by humans per year (3.1mSv).
|
Radiostereometric analysis - Symptomatic pseudoarthrosis
Definitive clinical evidence of pseudarthrosis (not fused, ˃ 2 degrees angular motion or absence of bone bridge) and scheduled for surgical exploration
|
The radiostereometric (RSA) patient exam (flexion and extension RSA images) presents additional radiation exposure to the patient above standard of care (additional radiographs).
Assuming 120kV, using three protocols (two loaded and one unloaded) per RSA exam results in a typical effective dose of approximately 2.04mSv per exam(single lumbar spine RSA at 120kV yields 0.68mSv,).
HBI recommends using 140kV for lumbar spine RSA and has conducted simulations to estimate the effective dose using higher kV settings.
140kV reduces the effective dose from 0.68mSv per spine RSA to 0.2mSV, resulting in a total effective dose per RSA exam of 0.6mSv.
In comparison, the estimated effective dose for a single standard lumbar spine x-ray is 1.2mSv.
This additional radiation exposure is considered to be minimal risk in consideration of the number of planar x-rays the patient will undergo as part of standard care, as well as average background radiation received by humans per year (3.1mSv).
|
Radiostereometric analysis - Asymptomatic pseudoarthrosis
Definitive clinical evidence of pseudarthrosis without scheduled surgical exploration.
|
The radiostereometric (RSA) patient exam (flexion and extension RSA images) presents additional radiation exposure to the patient above standard of care (additional radiographs).
Assuming 120kV, using three protocols (two loaded and one unloaded) per RSA exam results in a typical effective dose of approximately 2.04mSv per exam(single lumbar spine RSA at 120kV yields 0.68mSv,).
HBI recommends using 140kV for lumbar spine RSA and has conducted simulations to estimate the effective dose using higher kV settings.
140kV reduces the effective dose from 0.68mSv per spine RSA to 0.2mSV, resulting in a total effective dose per RSA exam of 0.6mSv.
In comparison, the estimated effective dose for a single standard lumbar spine x-ray is 1.2mSv.
This additional radiation exposure is considered to be minimal risk in consideration of the number of planar x-rays the patient will undergo as part of standard care, as well as average background radiation received by humans per year (3.1mSv).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intervertebral motion post-op lumbar fusion
Time Frame: 2 years
|
The purpose of this radiostereometric analysis (RSA) evaluation is to measure relative intervertebral motion in lumbar spinal fusions.
Two RSA loading provocation protocols will be employed in this study; sitting and supine extension.
Both loading protocols will be compard to a standard supine position which is used as an unloaded baseline protocol.
Induced intervetebral motion sets will be calculated between the two loaded states, sitting and supine extension, and the unloaded state.
The RSA micromotion results will be calculated and reported as translations and rotations about the three anatomic axes, maximum total point motion (MTPM) will be calculated as well.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: John Andreshak, MD, OAD Orthopaedics
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (ANTICIPATED)
January 1, 2015
Study Completion (ANTICIPATED)
January 1, 2016
Study Registration Dates
First Submitted
October 31, 2012
First Submitted That Met QC Criteria
November 2, 2012
First Posted (ESTIMATE)
November 6, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
June 11, 2013
Last Update Submitted That Met QC Criteria
June 10, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RSA100
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Degenerative Disc Disease
-
NuVasiveCompleted
-
NuVasiveCompleted
-
Spine BioPharma, IncMCRARecruitingLumbar Degenerative Disc DiseaseUnited States
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
NYU Langone HealthActive, not recruitingLumbar Degenerative Disc DiseaseUnited States
-
Bioventus LLCTerminatedLumbar Degenerative Disc Disease
-
Justin Parker Neurological InstituteTerminated
-
Eisai China Inc.Completed
-
Foundation for Orthopaedic Research and EducationCoreLink, LLCCompletedDegenerative Disc Disease Lumbar
Clinical Trials on Radiostereometric Analysis
-
University Hospital, CaenUnknown
-
State University of New York - Upstate Medical...Zimmer BiometCompletedOrthopedic Procedures | Spinal FusionUnited States
-
Helse-Bergen HFActive, not recruiting
-
State University of New York - Upstate Medical...DePuy-Acromed, Inc.CompletedSpinal Fusion | Lumbar DiscectomyUnited States
-
Midwest Orthopaedics at RushUnknownTotal Hip Arthroplasty | Acetabular CupUnited States
-
Spaarne GasthuisLeiden University Medical CenterActive, not recruitingKnee Osteoarthritis | Total Knee Arthroplasty | Total Knee ReplacementNetherlands
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Oxford University Hospitals NHS TrustUnknownMyelodysplastic Syndromes | LeukemiaUnited Kingdom